Clinical results of unconventional fractionation radiotherapy in central nervous system tumors

Tumori

Volumn 84, Issue 2, 1998, Pages 176-187

  Botturi, Marco ^a   Fariselli, Laura ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Altered fractionation; Central nervous system; Radiation therapy

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

BRAIN TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; PROGNOSIS; RADIATION HAZARD; RADIATION NECROSIS; REVIEW; SURVIVAL RATE;

EID: 0031802114     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169808400215     Document Type: Review

References (150)

1. Allen J., Nuremberg A., Donahue B.: A phase I/II pilot study employing hyperfractionated radiotherapy and adjuvant chemotherapy for high risk primitive neuroectodermal tumors. Ann. Neurol., 30: 457, 1991.
2. Aristizibal S.A., Caldwell W.L.: Time dose relationships in the treatment of glioblastoma multiforme. Radiology, 101: 201, 1971.
3. Baclesse F.: Carcinoma of the larynx. Brit. J. Radiol., 3: 1, 1949.
4. Bauman G.S., Gaspar L.E., Fisher B.S.: A prospective study of short course radiotherapy in poor prognosis glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys., 29: 835, 1994.
5. Berger S.M., Leibel S., Bruner M.S.: Primary central nervous system tumors of the supratentorial compartment. In: Cancer in the nervous system, V.A. Levin (ed.), Churchill Livingstone, New York: 57, 1996.
6. Bergonié J., Tribondeau L.: Interpretation des resultats de la électrotherapie. Compt. R. Acad. Sci., 143: 983, 1906.
7. Bernasconi V.: I gliomi: radioterapia. In: Manuale di neurooncologia clinica, P. Paoletti, G. Robustelli della Cuna, R. Knerich (eds.), Masson, Milano: 102, 1986.
8. Bernasconi V.: Radioterapia convenzionale dei gliomi cerebrali a lenta evoluzione. Osp. Magg., 88/1: 81, 1994.
9. Biti G., Santoni R., Ponticelli P.: Multiple daily fractionation in cerebral metastases. In: Proceeding of the 3rd European Conference on Clinical Oncology and Cancer Nursing, Stockolm, 1985.
10. Bleehen N.M., Witshire C.R., Plowman P.N.: A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytomas. Brit. J. Cancer, 43: 436, 1981.
11. Boiardi A., Silvani A., Milanesi I.: Primary glial tumor patients treated by combination Cisplatin and Etoposide. J. Neuroncol.,11: 165, 1991.
12. Brada M., Ross G.: Radiation therapy in the management of malignant gliomas. In: Clinical Neurology, W.K. A. Yung (ed.), Baillière Tindall, London: 319, 1996.
13. Brada M., Thomas G., Elyan S.: Improving the acceptability of high dose radiotherapy by reducing the duration of treatment accelerated radiotherapy high-grade glioma. Brit. J. Cancer, 71: 1330, 1995.
14. Buatti J.M., Marcus R.B., Mendenhall W.M.: Accelerated hyperfractionated radiotherapy for malignant glioma. Int. J. Radiat. Oncol. Biol. Phys., 34: 785, 1996.
15. Chang C.H., Horton J., Schoenfeld D.: Comparison postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer, 52: 997, 1983.
16. Chang C.H.: Sensitivity and tolerance for nervous tissues to ionizing radiation. In: Tumours of the central nervous system: modern radiotherapy in multidisciplinary management, C.H. Chang, E.M. Housepian (eds.), Masson, New York: 215, 1982.
17. Cohen L.: Clinical radiation dosage. Brit. J. Radiol., 22: 160, 1949.
18. Concannon J., Kramer J., Berry R.: The extent of intracranial gliomata at autopsy and its relationship to tecniques used in radiation therapy. Am. J. Roentgenol., 107: 84, 1960.
19. Constans J.P., Schlieger M.: Astrocytomes. In: Indications de la radiotherapie dans les tumeurs intracraniennes, Masson, Paris: 91, 1975.
20. Corn W.B., Curran W. J., Loeffler J.S.: Principles of radiotherapy. In: Cancer in the nervous system, Mc Black P., Loeffler J.S. (eds.), Blackwell Sci., Cambridge Mass: 178, 1997.
21. Coutard H.: Die Rontgenbehandlung der Epithelialen Krebse der Tonsillengegend, Strahlenther., 33: 249, 1929.
22. Curran W.J., Scott C.B., Nelson J.: A randomized trial of accelerated hyperfractionated radiation therapy and Bischloroethylnitrosurea for malignant glioma. Cancer, 70: 2909, 1992.
23. Curran W.J., Scott C.B., Horton J.: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J. Nat. Cancer Inst., 85: 704, 1993.
24. Curran W.J., Scott C.B., Yung W.K.A.: Radiation therapy Oncology Group PHILA PA 19107. No survival benefit of hyperfractionated radiotherapy to 72 Gy and Carmustine versus standard radiotherapy and Carmustine for malignant glioma patients: preliminary results of RTOG 9006. Proc. Am. Soc. Clin. Oncol., 15: 154, 1996.
25. De Crevoisier R., Pierg J.Y., Dendale R.: Radiothérapie des glioblastomes. Cancer Radiother., 1: 194, 1997.
26. Deeley Th.: Localized treatment to the brain. In: Modern Radiotherapy Oncology, Butterworths, Bristol: 131, 1974.
27. Deutsch M., Green S., Strike T.: Results of a randomized trial comparing BCNU plus radiotherapy, Streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy in the postoperative treatment of malignant glioma. Int. J. Radiat. Oncol. Biol. Phys., 16: 1398, 1989.
28. Deutsch M., Parson J.As., Mercado R.: Radiotherapy for intracranial metastases. Cancer, 34: 1607, 1974.
29. Diener-West M., Dobbin S.T., Phillips T.L.: Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int. J. Radiat. Oncol. Biol. Phys., 16: 669, 1989.
30. Douglas B., Worth A.: Superfractionation in glioblastoma multiforme: results of a phase II study. Int. J. Radiat. Oncol. Biol. Phys., 8: 1787, 1982.
31. Dutreix J.: Radiotherapie. In: Therapeutique des cancers, M. Tubiana (ed.), Flammarion, Paris: 109, 1986.
32. Edward M.S., Wara W., Urtasun R.C.: Hyperfractionated radiation therapy for brain stem glioma: a phaseI/II trial. J. Neurosurg., 70: 691, 1989.
33. Fallai C., Olmi P.: Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors and brain metastases). Radiother. Oncol., 43: 235, 1997.
34. Fariselli L., Leoni M., Boiardi A.: Radioterapia con dose frazionata non convenzionale. In: Gliomi maligni di alto grado intracerebrali, Boiardi A., Botturi M., Leoni M., Volterrani F. (eds.), Bi & Gi, Verona: 177, 1995.
35. Fine H., Dear K., Loeffler J.S.: Metanalysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer, 71: 2585, 1993.
36. Fine H., Pluard T.: Tumor angiogenesis: biology and therapeutic implications. In: Radiation Oncology, Mauch P.H., Loeffler Y.S. (eds.), p. 487, Saunders, Philadelphia, 1994.
37. Fine H.: The basis for current treatment recomendation for malignat gliomas. J. Neuroncol., 20: 111, 1994.
38. Folkman J., Handenschid C.C., Zetter B.K.: Long term culture of capillary endothelial cells. Proc. Natl. Acad. Sci., 76: 5217, 1979.
39. Forsyth P.A., Cairncross J.G.: Chemotherapy for malignant gliomas. In: Clinical neurology, Yung W.K.A. (ed.), p. 271, Baillière Tindall, London, 1996.
40. Fowler J.F., Stern B.E.: Dose time relationships in radiotherapy and validity of cell survival curve models. Brit. J. Radiol., 36: 163, 1963.
41. Fraass B.: Conformal therapy dose escalation studies: clinical results. In: Conformal therapy and others advanced irradiation tecniques, Barthelink H. (ed.), p. 153 ESTRO Ed., Amsterdam, 1996.
42. Franchin G., Minatel E., Roncadin M.: Accelerated split course regimen in the treatment of brain metastases. Radiother. Oncol., 12: 39, 1988.
43. Freeman C., Bourgouin P.M., Sanford P.M.: Long term survivors of 26 children brain stem gliomas treated with hyperfractionated radiotherapy. Cancer, 77: 555, 1996.
44. Freeman C., Krischer J., Sanford R.: Final results of a study of escalation doses of hyperfrationated radiotherapy in brain stem tumors in children. A Pediatric Oncology Group Study. Int. J. Radiat. Oncol. Biol. Phys., 27: 197, 1993.
45. Freeman C., Krischer J., Sanford R.: Hyperfractionated radiation therapy in brain stem tumors. Cancer, 68: 474, 1991.
46. Freeman C., Krischer J., Sanford R.: Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Study Group. Int. J. Radiat. Oncol. Biol. Phys., 15: 311, 1988.
47. Fu K.K., Cox J.D., Pajak T.F.: RTOG altered fractionation trials. In: Radiation Research, W. C. Dewey, M. Edington, R.M. Fry (eds.), p. 567, Academic Press, St. Diego, 1992.
48. Fulton S., Urtasun R.C., Shin K.H.: Misonidazole combined with hyperfractionation in the management of malignat glioma. Int. J. Radiat. Oncol. Biol. Phys., 10: 1709, 1984.
49. Gardani G., Palazzi M.: Treatment plan evaluation. In: Evaluation of 3D treatment planning systems for clinical use in radiotherapy, p. 159, Andreucci L. (ed.), Giardini, Pisa, 1996.
50. Gebber R.D., Larson M., Borgelt B.B.: Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer, 48: 1749, 1981.
51. Glinski B.: Postoperative hypofractionated versus convetionally fractionated radiotherapy in malignat gliomas. J. Neuroncol., 16: 167, 1993.
52. Goffman T., Dachowski L., Bobo H.: Long term follow up on National Cancer institute phase I/II study of glioblastoma multiforme treated with lododeoxyuridine and hyperfrationated irradiation. J. Clin. Oncol., 10: 264, 1996.
53. Gonzalez D., Menten J., Bosch D.: Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study. Radiother. Oncol., 32: 98, 1994.
54. Green S.B., Byar D.P., Walker M.D.: Comparison of Carmustine, Procarbazione and high dose Methylprednisolone as additions to surgery and radiotherapy for the treatment of malignat gliomas. Cancer Treatm. Rep., 67: 121, 1983.
55. Hatlevoll R., Lindegaard K., Hagen S.: Combined modality treatment of operated astrocytomas grade 3 and 4. Cancer, 56: 41, 1985.
56. Hildebrand J., Sahmond T., Mignolet T.: Adjuvant therapy with Dibromodulcitol and BCNU increases survival of adult with malignant gliomas. Neurology, 44: 1479, 1994.
57. Hindo W.A., De Trana F.A., Lee M.S.: Large dose increment irradiation in the treatment of cerebral metastases. Cancer, 26: 138, 1970.
58. Hochberg F.H., Pruitt A.: Assumptions in the radiotherapy of glioblastomas. Neurology, 30: 907, 1980.
59. Horiot J., Van den Bogaert W., Ang K.: EORTC trial using radiotherapy with multiple fractions per day. A 1978-1987 survey. In: Frontiers of Radiation Therapy and Oncology, Vaeth J.M., Meyer J. (eds.), p. 149, Karger, Basel, 1988.
60. Hoshino T., Ahn D., Prados M.D.: Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int. J. Cancer, 53: 550, 1993.
61. Hoshino T., Ito S., Asai A.: Cell kinetic analysis of human brain tumors by in situ double labelling with bromoceoxyuridine and iododeoxyuridine. Int. J. Cancer, 50: 1, 1992.
62. Hoshino T.: Cell kinetics of glial tumors. Rev. Neurol., 148: 396, 1992.
63. Hoskin P.G., Crow J., Ford H.T.: The influence of extente and local management on the outcome of radiotherapy for brain metastases. Int. J. Radiat. Oncol. Biol. Phys., 19: 111, 1990.
64. Ito S., Chandler K.L., Prados M.D.: Proliferative potential and prognostic evaluation of low-grade astrocytomas. J. Neurosurg., 19: 1, 1994.
65. Keim H., Otthoff P., Schmidt K.: Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. Radiother. Oncol., 9: 21, 1987.
66. Kelly P.J., Daumas-Duport C., Kinspert D.B.: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J. Neurosurg., 66: 865, 1987.
67. Kinsella T., Collins J., Rowland J.: Pharmacology and Phase I/II study of continuous intravenous infusions of Iododeoxyuridine and hyperfrationated radiotherapy in patients with glioblastoma multiforme. J. Clin. Oncol., 6: 871, 1988.
68. Kleinberg L., Slyck T., Enger Ch.: Short course radiotherapy is an appropriate option for most malignant glioma patients. Int. J. Radiat. Oncol. Biol. Phys., 38: 31, 1997.
69. Knerich R., Paoletti P., Robustelli della Cuna G.: Biologia e biochimica. In: Manuale di neurooncologia clinica, Paoletti P., Robustelli delle Cuna G., Knerich R. (eds.), p. 33, Masson, Milano, 1986.
70. Kramer S.: Tumour extent as a determining factor in radiotherapy of glioblastomas. Acta Radiol., 8: 11, 1969.
71. Kretcshmar C., Tarbelln, Barnes P.: Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. Cancer, 72: 1404, 1993.
72. Kristiansen K., Hagen S., Kollevold T.: Combined modality therapy of operated astrocytomas grade III and IV. Cancer, 47: 649, 1981.
73. Kyritsis A.P., Yung W.A.: Molecular genetics and tumour suppressor genes in gliomas. In: Clinical Neurology, Yung W.K.A. (ed.), p. 295, Baillière Tindall, London, 1996.
74. Lartigau E.: De la biologie à la radiothérapie: état des lieux et prespectives d'avenir. Cancer Radiother., 1: 471, 1997.
75. Leibel S. A., Sheline G. E.: Radiation therapy for neoplasm of the brain. J. Neurosurg., 66: 1, 1987.
76. Leibel S., Scott C., Pajak T.: The management of malignant gliomas with radiation therapy. Semin. Radiat. Oncol., 1: 32, 1991.
77. Levin V. A., Silver P., Hannigan J.: Superiority of post-radiotherapy adiuvant chemotherapy with CCNU, Procarbazine and Vincristine (PCV) over BCNU for anaplastic gliomas. NCOG 6G61 final report. Int. J. Radiat. Oncol. Biol. Phys., 18: 321, 1990.
78. Levin V.A., Maor M.H., Thall P.F.: Phase II study of accelerated fractionation radiation therapy with Carboplatin followed by Vincristine chemotherapy for the treatment of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys., 33: 357, 1995.
79. Lindgren M.: On tolerance of brain tissue and sensitivity of brain tumors of irradiation. Acta Radiol., 1: 170, 1958.
80. Littman P.H., Jarret P., Balaniuk L.T.: Pediatric brain stem gliomas. Cancer, 45: 2787, 1980.
81. Loeffler J.S., Shrieve D.C., Coleman N.: Chemoradiation and adjuvant chemotherapy for glioblastoma: why does so much therapy yield so little improvement in survival ? Int. J. Radiat. Oncol. Biol. Phys., 33: 531, 1995.
82. Lombardi G.: La rontgenterapia dei gliomi cerebrali. Radiol. Med., 40: 1088, 1954.
83. Marcial-Vega V.A., Wharam M.D., Leibel S.: Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 16: 1419, 1989.
84. Marks J., Baglan R., Prassad S.: Cerebral radionecrosis incidence and risk in relation to dose, time, fraction and volume. Int. J. Radiat. Oncol. Biol. Phys., 7: 243, 1981.
85. Martinenghi C., Fossati V.: Frazionamento della dose. In: Radiobiologia, p. 209, Cortina Ed., Milano, 1997.
86. Mc Whirter R.: Tumours of the brain and spinal cord. In: British Practice in Radiotherapy, Carling E.R., Windeier B.W., Smithers D.W. (eds.), p. 330, Butterworth, London, 1955.
87. Nelson D.F., Curran W.J., Scott C.B.: Hyperfrationated radiation therapy and Bischloroethylnitrosurea in the treatment of malignant glioma: possible advantage observed at 72.0 Gy in 1.2 G, b.i.d fractions: report of the Radiation Therapy Oncology Group Protocol 8302. Int. J. Radiat. Oncol. Biol. Phys., 25: 193, 1993.
88. Nelson D.F., Diener-West M., Horton J.: Combined modality approach to treatment of malignant gliomas. Reevaluation of RTOG 7401 / ECOG 1374 with long term follow-up. Nat. Cancer Inst. Monogr., 6: 279, 1988.
89. Nicholas M.K., Prados M.D., Larson D.A.: Malignant astrocytomas. In: Cancer in the nervous system, Black P. Mc., Loeffler J.S. (eds.), p. 464, Blackwell Sci, Cambridge Mass., 1997.
90. Nordijk E.M., Vecht C.H., Haaxma-Reiche H.: The choice of treatment of single brain, metastases should be based on extracranial tumor activity and age. Int. J. Radiat. Oncol. Biol. Phys., 29: 711, 1994.
91. Packer R.J., Zimmerman R.A., Kaplan A.: Early cysticnecrotic changes after hyperfractionated radiation therapy in children with brain stem gliomas. Data from the Children Cancer Group. Cancer, 71: 2666, 1993.
92. Packer R.J., Allen J.C., Goldwin J.L.: Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 72 Gy. Ann. Neurol., 27: 167, 1990.
93. Packer R.J., Boyett J.M., Zimmerman R.A.: Hyperfractionated radiotherapy (72 Gy) for children with brain stem gliomas: a Children's Cancer Group phase I.II study. Cancer, 72: 1414, 1993.
94. Packer R.J., Boyett J.M., Zimmerman R.A.: Outcome of children with brainstem glioma after treatment with 78 Gy of hyperfractionated radiotherapy. Cancer, 74: 1827, 1994.
95. Packer R.J., Nicholson H.S., Johnson D.L.: Dilemmas in the treatment of childhood brain tumor: brain stem glioma. Pediatr. Neurosurg., 17: 37, 1992.
96. Packer R.J., Vezina G., Chadduck W.M.: Astrocytomas in special locations: cerebellum, brain stem and diencephalon. In: Cancer in the nervous system, Black P. Mc, Loeffler J.S. (eds.), p. 492, Blackwell Sci., Cambridge Mass., 1997.
97. Pancoast H.K.: Treatment of brain tumors by radiation. Am. J. Roentgenol., 9: 42, 1922.
98. Patchell R.: Brain metastases. In: Cancer in the nervous system, P. Mc Black, J.S. Loeffler (eds.), p. 653, Blackwell Sci., Cambridge Mass., 1997.
99. Payne D.G., Simpson W.J., Keen C.: Malignant astrocytoma hyperfractionated and standard radiotherapy with chemotherapy in randomized prospective clinical study. Cancer, 50: 2301, 1982.
100. Peters L.J., Ang K.K.: Unconventional fractionation schemes in radiotherapy. In: Important advances in oncology, De Vita V.T., Hellman S., Rosenberg S.A. (eds.), p. 269, Lippincott Co, Philadephia, 1986.
101. Philippon J.H., Clemenceau S.H., Foncin J.F.: Supratentorial low-grade astrocytomas in adults. J. Neurosurg., 32: 554, 1993.
102. Phillips Th., Wasseman T.H.: Promise of radiosensitizers and radioprotectors in the treatment of human cancer. Cancer Treat. Rep., 68: 291, 1984.
103. Pierce C.B., Bouchard J.: Role of radiation therapy in the control of malignant neoplasms of the brain and spinal cord. Radiology, 55: 337, 1950.
104. Prados M.D., Wara W.M., Edward M.S.: Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a pilot study. Int. J. Radiat. Oncol. Biol. Phys., 32: 438, 1994.
105. Prados M.D., Wara W.M., Edward M.S.: The treatment of brainstem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 32: 85, 1995.
106. Regaud Cl.: Sur la radiommunisation des tissus cancéreux et sur le mechanisme de l'action des rayons X et des rayons gamma de radium sur les cellules et les tissus vivants en general. Bull. Acad. Paris, 91: 604, 1921.
107. Reinchental E., Feldman Z., Cohen M.L.: Hemispheric supratentorial low-grade astrocytomas. Neurochirurgia, 35: 18, 1992.
108. Reisner A.: Hautherytem und Rontgenstrahlung. Ergebr. Med. Strahlenforsch., 6: 1, 1933.
109. Rostomily R.C., Keles G.E., Berger M.S.: Radical surgery in the management of low- and high-grade gliomas. In: Clinical Neurology, Yung W.K.A. (ed.), p. 545, Baillière Tindall, London, 1996.
110. Rubin P., Casarett G.W.: Clinical Radiation Pathology. Saunders, Philadelphia, 1968.
111. Sachs E.: The treatment of glioblastomas with radium. Neurosurg., 11: 119, 1954.
112. Sannazzari G.L.: La radioterapia dei gliomi maligni. In: Biopatologia e clinica dei tumori del sistema nervoso centrale, Paoletti P., Shiffer D. (eds.), p. 65, Minerva Medica, Torino, 1984.
113. Sause W., Scott C., Krisch R.: PhaseI/II trial of accelerated fractionation in brain metastase RTOG 8528. Int. J. Radiat. Oncol. Biol. Phys., 26: 653, 1993.
114. Sautter-Bihl M.I., Bacsay E., Liebermeister E.: Radiotherapy of glioblastomas. Is shortening of the treatment justifiable? Strahlenther. Oncol., 167: 7, 1991.
115. Schwarz G.: Entwicklung Prinzipien und Biologischen Grundlagen der Roentgentherapeutischen Bestrahlungsmethodik. Strahlenther., 58: 523, 1937.
116. Seitz A., Wintz H.: Unsere Methode der Roentgentherapie und ihre Erfolge. Strahlenther., 1: 22, 1920.
117. Shapiro W.R., Green S.B., Burger P.C.: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. J. Neurosurg. 71: 1, 1989.
118. Shaw E. G., Daumas-Duport C., Scheithauer B. W.: Radiation therapy in the management of low-grade supratentorial astrocytomas. J. Neurosurg., 70: 853, 1989.
119. Shaw E.G., Scheithauer B.W., Dinapoli R.P.: Low-grade hemispheric astrocytomas. In: Cancer of the nervous system, Mc Black P., Loeffler J.S. (eds.), p. 441, Blackwell Sci., Cambridge Mass., 1997.
120. Sheline G.E.: Radiotherapy of adult primary cerebral neoplasms. In: Oncology of the nervous system. Walker M.D. (ed.), p. 223, Martinus Nijhoff Pub., Boston, 1983.
121. Sheline G.E., Wara W.A., Smith V.: Therapeutic irradiation and brain injury. Int. J. Radiat. Oncol. Biol. Phys., 6: 1215, 1980.
122. Shenouda G., Souhami L., Freeman C.: Accelerated fractionation for high-grade cerebral astrocytomas. Cancer, 67: 2247, 1991.
123. Shibuya M., Ito S., Miwa T.: Proliferative potential of brain tumors: Analysis with KI-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling and nuclear organizer region counts. Cancer, 71: 199, 1993.
124. Shiffer D.: Blood vessel architecture and angiogenesis in gliomas. In: Brain Tumors, p. 178, Springer Verlag, Berlin, 1997.
125. Shiffer D.: Effects of external radiotherapy on the human brain. In: Brain Tumors, p. 523, Springer Verlag, Berlin, 1997.
126. Shin K., Muller P., Geggie P.: Superfractionation radiation therapy in the treatment of malignant astrocytomas. Cancer, 52: 2040, 1983.
127. Shin K., Urtasun R., Fulton D.: Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytomas. Cancer, 56: 758, 1985.
128. Shrieve D., Wara W., Edward M.: Hyperfractionated radiation therapy for glioma of the brainstem in children and in adults. Int. J. Radiat. Oncol. Biol. Phys., 24: 599, 1992.
129. Simpson W.J., Platts M.E.: Fractionation study in the treatment of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys., 1: 639, 1976.
130. Skowronska-Grads A.: Hyperfractionated radiotherapy for brain stem tumours in children. Radiother. Oncol., 33: 2, 1995.
131. Slotman B.J., Kralendonk J.H., Van Alphen H.M.: Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int. J. Radiat. Oncol. Biol. Phys., 34: 895, 1996.
132. Strandquist M.: Studien über die Kumulative Wirkung der Röntgenstahlen bei Fraktionierung. Acta Radiol., 55: 1, 1944.
133. Sullivan F.J., Herscher L.L., Cook J.A.: National Cancer Institute phase II study of high-grade glioma treated with accelerated hyperfractionated radiation therapy and Iododeoxyuridine: results in anaplastic astrocytoma. Int. J. Radial. Oncol. Biol. Phys., 30: 583, 1994.
134. Takakura K., Sano K., Hojo S.: Metastatic tumors of central nervous system. Igaku-Shoin, Tokyo, 1982.
135. Tamura M., Nakamura M., Kunimine H.: Large dose fraction radiotherapy in the treatment of glioblastoma. J. Neuroncol., 7: 113, 1989.
136. Thames H.D., Hendry J.H.: Fractionation in radiotherapy. Taylor Francis, Philadelphia, 1987.
137. Thomas R., James N., Guerrero D.: Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high-grade glioma. Radiother. Oncol., 33: 113, 1994.
138. Tubiana M.: Cell kinetics and radiation oncology. Int. J. Radiat. Oncol. Biol. Phys., 8: 1471, 1982.
139. Van der Kogel A.J.: Central nervous system radiation injury in small animal models. In: Radiation injury to the nervous system. Gutin P.H., Leibel S.A., Sheline G.E. (eds.), p. 91, Raven Press, New York, 1991.
140. Van der Kogel A.J.: Radiation tolerance of the spinal cord. In "Radiobiological Research and Radiotherapy", IAEA, Vienna: 85, 1977.
141. Van Glabbeke M., Karim A.B., Hames H.: No improvement in survival by an increased radiation dose given postoperalively to patients with low-grade brain tumors: an EORTC randomized phase III study. Proc. ASCO, 14: 145, 1995.
142. Vasario E.: La radioterapia esterna frazionata dei gliomi. In: Biologia, diagnosi e trattamento dei gliomi maligni, Carapella C., Jandolo B., Soffietti R. (eds.), p. 151, AINO, Roma, 1996.
143. Vertosick F.T., Selfer R.G., Arena V.C.: Survival of patients with well differentiated astrocytomas diagnosed in the era of computed tomography. J. Neurosurg., 28: 501, 1991.
144. Walker M.D., Alexander E., Hunt W.E.: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic glioma. J. Nerurosurg., 49: 333, 1978.
145. Walker M.D., Strike T.S., Sheline G.E.: An analysis of dose effect relationship in the radiotherapy of malignant glioma. Int. J. Radiat. Oncol. Biol. Phys., 5: 1725, 1979.
146. Walner K., Galicich J., Krol G.: Patterns of failure following treatment for glioblastoma and anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys., 16: 1405, 1989.
147. Wara W.M., Edward M.S., Levin V.A.: A new treatment regimen for brain stem glioma: a pilot study of the Brain Center and Children Study Group. Int. J. Radiat. Oncol. Biol. Phys., 12: 143, 1986.
148. Withers H.R., Peters L.J., Kogelnik P.: The pathobiology of late effects of irradiation. In: Radiation Biology in Cancer Resarch, Meyn R.E., Withers R.H. (eds.), p. 439, Raven Press, New York, 1980.
149. Withers H.R.: Hyperfractionation. In: Current topics in Clinical Radiobiology of tumors, Beck-Bornholdt H.P. (ed.), p. 45, Springer Verlag, Berlin, 1993.
150. Zuppinger A.: Spätveränderungen nach Protrahiert Fraktionierte Römgenbestrahlung im Bereich der oberen Luft und Speisewege. Strahlenther., 70: 361, 1941.